The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy
about
Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reportsHepatitis B reactivation and rituximab in the oncology practice.Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.Management of hepatitis B reactivation in patients receiving cancer chemotherapy.Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management.Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis.Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.Improving testing for hepatitis B before treatment with rituximab.A drug safety evaluation of rituximab and risk of hepatitis B.Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis.Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance.Hepatitis B reactivation after chemotherapy: two decades of clinical research.Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: a decision analysis model.An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study.Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy.
P2860
Q34627978-031FF36B-D049-4B60-AB10-E2C28C02DCF8Q34734311-04F05671-2A25-4A09-ACB0-4E4356779EABQ34854165-21ABB4DF-8D84-496E-8D57-49182C399E4EQ35583718-58A17ED7-E8A5-4FF9-826C-2EA026831634Q36001152-0D1981C8-66AD-4A6B-B78E-C5EDB6E47965Q36220459-003AC492-32DE-429A-BE10-D893F86EA957Q36379054-BB2641AB-61FF-4819-8D8E-CC10C5F2C5F6Q36581066-AC720955-DAC9-4C51-B0EC-567CE6F207D0Q36752181-0ADC0895-6C26-473C-8FE3-83AC454490B6Q36951280-70DE4F56-F2DA-4261-9324-8940591F48A9Q36988414-AC65CF0B-AB99-4212-9B7E-95089BE7B6AAQ37124256-1A059211-042C-4CFC-BDF4-894A74EA5FF5Q37229995-FF445DBB-5B9C-440D-B614-AECF84C4A139Q38211373-76B903BA-B1EB-4973-82BA-D5C5DC39B53DQ40285910-907F2A08-8EFF-495E-834E-B488ECB0821AQ42145809-BDF9ED56-7915-485A-8AF4-750D78C887E1Q42590960-110993C5-F422-4221-99DD-7273F7633EB1Q45934876-644AE6B7-8106-4760-9E1D-D278D602B0B4Q51841676-CC9AF37F-1F4F-4E61-B156-CF74903C56C0Q52604921-AE6060AA-B735-4AE3-B3E3-720D1573B13B
P2860
The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The prophylactic use of lamivu ...... receive cytotoxic chemotherapy
@ast
The prophylactic use of lamivu ...... receive cytotoxic chemotherapy
@en
The prophylactic use of lamivu ...... in hepatitis-B surface antigen
@nl
type
label
The prophylactic use of lamivu ...... receive cytotoxic chemotherapy
@ast
The prophylactic use of lamivu ...... receive cytotoxic chemotherapy
@en
The prophylactic use of lamivu ...... in hepatitis-B surface antigen
@nl
prefLabel
The prophylactic use of lamivu ...... receive cytotoxic chemotherapy
@ast
The prophylactic use of lamivu ...... receive cytotoxic chemotherapy
@en
The prophylactic use of lamivu ...... in hepatitis-B surface antigen
@nl
P2093
P1476
The prophylactic use of lamivu ...... receive cytotoxic chemotherapy
@en
P2093
Cheolwon Suh
Eunkyoung Kim
Gyeong-Won Lee
Jae-Hwan Lee
Jae-Lyun Lee
Jung-Shin Lee
Kyoo-Hyung Lee
Min-Hee Ryu
Sang-We Kim
Seung-Bae Kim
P304
P356
10.3346/JKMS.2003.18.6.849
P577
2003-12-01T00:00:00Z